# Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer

> **NCT00006123** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Beth Israel Deaconess Medical Center**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** trastuzumab
- **DRUG:** carboplatin
- **DRUG:** carmustine
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** thiotepa
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00006123
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2000-07
- **Primary completion:** 2000-07
- **Final completion:** 2000-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Never started
- **Last updated:** 2018-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006123, "Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00006123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*